Is celiac disease holding you back? If so, consider joining the FB102-301 study for people who have celiac disease who are currently on a gluten-free diet. The phase 2 FB102-301 study is researching a potential new…
Continue ReadingNew Phase 2 Clinical Trial: TEV-CeD2 Study
Continue ReadingThe Celiac Disease Foundation on May 22 awarded its first Celiac Disease Policy Leadership Award to U.S. Representative Betty McCollum (MN-04) for her distinguished service and advocacy on behalf of the celiac disease patient community. Among other initiatives, she established the bipartisan Congressional Celiac Disease Caucus, which has significantly increased federal recognition of celiac disease.
Continue ReadingThe future of celiac disease research is promising, with exciting advancements in diagnosis and therapies presented at the 2024 Digestive Disease Week® (DDW) conference in Washington, D.C. Read on for updates the Celiac Disease Foundation team gathered from lectures, posters, and panel discussions at the conference.
Continue ReadingIn March, our Celiac Disease Foundation staff—most of whom are lived experience experts—headed to the halls of Congress for our annual round of bipartisan meetings with key members of Congress to advocate for the interests of our patient and research communities.
Continue ReadingThe SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference.
Continue ReadingCongratulations to Celiac Disease Foundation research partner Takeda Pharmaceuticals and its Medical Director Dan Leffler on recent media attention for three potential celiac disease therapies.
Continue ReadingThe ILLUMINATE Studies are phase 2 clinical research studies evaluating an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingThe CeDLara Study is for adults who have been diagnosed with celiac disease and are still experiencing symptoms despite following a gluten-free diet.
Continue ReadingOn April 9, 2019, Marilyn G. Geller, CEO of the Celiac Disease Foundation, testified before the House Appropriations Subcommittee overseeing the funding for the Department of Health and Human Services, including the National Institutes of Health (NIH).
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...